Your browser doesn't support javascript.
loading
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Chui, Noreen Nog-Qin; Cheu, Jacinth Wing-Sum; Yuen, Vincent Wai-Hin; Chiu, David Kung-Chun; Goh, Chi-Ching; Lee, Derek; Zhang, Misty Shuo; Ng, Irene Oi-Lin; Wong, Carmen Chak-Lui.
Affiliation
  • Chui NN; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Cheu JW; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Yuen VW; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Chiu DK; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Goh CC; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Lee D; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Zhang MS; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Ng IO; ShenZhen Hospital, The University of Hong Kong, Shenzhen, China.
  • Wong CC; Department of Pathology, The University of Hong Kong, Hong Kong.
Hepatol Commun ; 6(1): 178-193, 2022 01.
Article in En | MEDLINE | ID: mdl-34558800

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / Carcinoma, Hepatocellular / Programmed Cell Death 1 Receptor / MARVEL Domain-Containing Proteins / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hepatol Commun Year: 2022 Type: Article Affiliation country: Hong Kong

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / Carcinoma, Hepatocellular / Programmed Cell Death 1 Receptor / MARVEL Domain-Containing Proteins / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hepatol Commun Year: 2022 Type: Article Affiliation country: Hong Kong